Dermatomyositis presenting in pregnancy.
We report the onset of dermatomyositis in a woman pregnant 38-weeks who subsequently delivered a healthy infant. The disease improved rapidly following delivery. The association of dermatomyositis with pregnancy is unusual, and fetal outcome may be adversely affected.
Harris
A
A
Department of Dermatology, Stoke Mandeville Hospital NHS Trust, Aylesbury, Bucks, U.K.
Webley
M
M
Usherwood
M
M
Burge
S
S
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003882:Dermatomyositis / Q000188:drug therapy* / Q000473:pathology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000473:pathology
D000893:Anti-Inflammatory Agents; D011239:Prednisolone; D008775:Methylprednisolone